rAAV2-U1a-hELP1

N/A

Report date: 2025/03/07 13:58:54

Base Information

Drug NamerAAV2-U1a-hELP1
Drug Alias NameRecombinant adeno-associated virus expressing the human ELP1 generAAV2-U1a-hELP1AAV2-U1a-hELP1
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionElongator complex protein 1 modulatorsGene transference
TargetsElongator complex protein 1Fibroblast growth factor 2
Therapy Area/IndicationsOptic Nerve Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTikun Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesTikun Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsOptic Nerve Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A